See the DrugPatentWatch profile for emgality
Is Emgality Approved for Tension Headaches?
No, Emgality (galcanezumab) is FDA-approved only for episodic or chronic migraine prevention in adults. It targets CGRP, a protein involved in migraine pain pathways, but tension headaches stem from muscle tension and stress, not CGRP.[1]
Does It Help Tension Headaches Off-Label?
Limited evidence suggests no reliable benefit. Clinical trials focused solely on migraines, with no dedicated studies for tension-type headaches (TTH). Small case reports and patient forums mention occasional overlap relief if tension headaches coexist with migraines, but experts like the American Headache Society do not recommend it for pure TTH due to lack of data and high cost (~$700/month).[2][3]
Why Might People Try It Anyway?
Some patients with mixed headache types (migraine + tension) report partial relief in anecdotal reviews on sites like Drugs.com or Reddit, possibly from reduced overall headache frequency. However, placebo effects or misdiagnosis explain many cases. A 2022 review in Headache journal found CGRP blockers ineffective for non-migraine headaches.[4]
What Works Better for Tension Headaches?
First-line treatments include:
- OTC pain relievers like ibuprofen or acetaminophen.
- Stress management (e.g., CBT, physical therapy).
- Muscle relaxants or tricyclic antidepressants (e.g., amitriptyline) for chronic cases.
Guidelines from the American Academy of Neurology prioritize these over injectables like Emgality.[5]
Risks of Using Emgality for Tension Headaches
Common side effects: injection-site reactions, constipation. Rare risks: allergic reactions, hypertension. Off-label use lacks insurance coverage and long-term safety data for TTH.[1]
[1]: FDA Label for Emgality
[2]: American Headache Society Position Statement on CGRP Monoclonal Antibodies
[3]: Drugs.com User Reviews for Emgality
[4]: Headache Journal Review (2022): CGRP Inhibitors in Non-Migraine Headaches
[5]: AAN Guidelines for Tension-Type Headaches (2019)